3D-QSAR Studies on the Inhibitory Activity of Trimethoprim Analogues against Escherichia coli Dihydrofolate Reductase

Vijayaraj, Ramadoss ; Lakshmi Vasavi Devi, Mekapothula ; Subramanian, Venkatesan ; Chattaraj, Pratim Kumar (2012) 3D-QSAR Studies on the Inhibitory Activity of Trimethoprim Analogues against Escherichia coli Dihydrofolate Reductase Chemical Biology & Drug Design, 79 (6). pp. 935-942. ISSN 17470277

Full text not available from this repository.

Official URL: http://doi.org/10.1111/j.1747-0285.2012.01351.x

Related URL: http://dx.doi.org/10.1111/j.1747-0285.2012.01351.x

Abstract

Three-dimensional quantitative structure activity relationship (3D-QSAR) study has been carried out on the Escherichia coli DHFR inhibitors 2,4-diamino-5-(substituted-benzyl)pyrimidine derivatives to understand the structural features responsible for the improved potency. To construct highly predictive 3D-QSAR models, comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods were used. The predicted models show statistically significant cross-validated and non-cross-validated correlation coefficient of inline image and inline image, respectively. The final 3D-QSAR models were validated using structurally diverse test set compounds. Analysis of the contour maps generated from CoMFA and CoMSIA methods reveals that the substitution of electronegative groups at the first and second position along with electropositive group at the third position of R2 substitution significantly increases the potency of the derivatives. The results obtained from the CoMFA and CoMSIA study delineate the substituents on the trimethoprim analogues responsible for the enhanced potency and also provide valuable directions for the design of new trimethorpim analogues with improved affinity.

Item Type:Article
Source:Copyright of this article belongs to John Wiley & Sons, Inc
ID Code:133819
Deposited On:30 Dec 2022 09:32
Last Modified:30 Dec 2022 09:32

Repository Staff Only: item control page